Position in BMY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$204,435
-$44,595 QoQ
Shares Held
3,548
-1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#2,147
of 2,506 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORRIS PERNE & FRENCH LLP/MI holds $41,974,464 across 6 Drug Manufacturers - General names. BMY ranks #6 (0.5% of the industry book) .
All Filings in BMY
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $204,435 | 3,548 | Shares | Sole | 2026-07-21 | |
| 2023-03-31 | $249,030 | 3,593 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $272,186 | 3,783 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $512,132 | 7,204 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $21,008,064 | 272,832 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $20,523,913 | 281,034 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $17,513,429 | 280,889 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $16,468,371 | 278,323 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $18,226,357 | 272,768 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $16,930,014 | 268,177 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $14,675,801 | 236,592 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $13,817,684 | 229,187 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $13,120,867 | 223,144 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $12,241,618 | 219,620 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||